Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Your reliable CDMO partner - agile, scalable, top-quality Small Molecule API & HPAPI solutions from concept to market

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    An Enquiry

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Pilocarpine HCl

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 7,154Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Orasis Pharmaceuticals Expands Access to Qlosi
    Orasis Pharmaceuticals Expands Access to Qlosi

    13 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/orasis-pharmaceuticals-expands-access-to-qlosi-with-new-starter-packs-for-eye-care-professionals-bolstering-commerical-rollout-302613523.html

    PR NEWSWIRE
    13 Nov 2025
    Share Share
    FDC’s Generics Pilocarpine Hydrochloride Receives Approval in US
    FDC’s Generics Pilocarpine Hydrochloride Receives Approval in US

    02 Oct 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217052

    FDA
    02 Oct 2025
    Share Share
    Orasis Pharmaceuticals Licenses Qlosi™ Ophthalmic Solution In Korea
    Orasis Pharmaceuticals Licenses Qlosi™ Ophthalmic Solution In Korea

    16 Oct 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/orasis-pharmaceuticals-announces-licensing-agreement-with-optus-pharmaceuticals-for-commercialization-of-qlosi-pilocarpine-hydrochloride-ophthalmic-solution-0-4-in-korea-302277027.html

    PR NEWSWIRE
    16 Oct 2024
    Share Share
    TB, Asthma, Glaucoma, Bipolar Meds To Rise By 50% Cost by NPPA
    TB, Asthma, Glaucoma, Bipolar Meds To Rise By 50% Cost by NPPA

    15 Oct 2024

    // FINANCIALXPRESS

    https://www.financialexpress.com/business/healthcare-tuberculosis-asthma-glaucoma-and-bipolar-disorder-medicines-to-get-costlier-by-50-percent-as-nppa-announces-price-hike-3641256/

    FINANCIALXPRESS
    15 Oct 2024
    Share Share
    Orasis Pharmaceuticals Strengthens Leadership Team For Qlosi
    Orasis Pharmaceuticals Strengthens Leadership Team For Qlosi

    14 Oct 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/orasis-pharmaceuticals-strengthens-leadership-team-with-key-hires-to-support-the-launch-of-qlosi-pilocarpine-hydrochloride-ophthalmic-solution-0-4-302274366.html

    PR NEWSWIRE
    14 Oct 2024
    Share Share
    Orasis Pharma Completes $78 Million Financing to Launch Qlosia
    Orasis Pharma Completes $78 Million Financing to Launch Qlosia

    08 Oct 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/orasis-pharmaceuticals-completes-78-million-financing-to-support-commercial-launch-of-qlosi-pilocarpine-hydrochloride-ophthalmic-solution-0-4-302269236.html

    PR NEWSWIRE
    08 Oct 2024
    Share Share